Actinium Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ATNM
CUSIP
00507W206
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00507W206 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Vanguard Group Inc 13G/A 4.4% 7/29/2025
Event 6/30/2025
BlackRock, Inc. 13G/A 1.5% 7/16/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 70.2 k $78.6 k
2026 Q2 48 5.29 M $5.18 M
2026 Q1 56 5.30 M $5.27 M
2025 Q4 63 5.41 M $7.36 M
2025 Q3 64 5.15 M $8.24 M
2025 Q2 66 5.48 M $7.67 M
2025 Q1 73 8.20 M $13.2 M
2024 Q4 74 8.13 M $10.2 M
2024 Q3 77 8.47 M $15.9 M
2024 Q2 82 7.36 M $54.4 M
2024 Q1 77 6.90 M $54.0 M
2023 Q4 67 5.89 M $29.9 M
2023 Q3 63 5.76 M $34.1 M
2023 Q2 76 6.04 M $44.8 M
2023 Q1 71 4.76 M $45.0 M
2022 Q4 67 4.58 M $48.8 M
2022 Q3 63 2.88 M $21.2 M
2022 Q2 58 2.48 M $11.9 M
2022 Q1 47 1.83 M $9.37 M
2021 Q4 52 1.98 M $11.5 M
2021 Q3 50 1.93 M $17.1 M
2021 Q2 44 1.73 M $13.7 M
2021 Q1 47 1.31 M $9.99 M
2020 Q4 56 2.05 M $16.0 M
2020 Q3 45 2.39 M $23.1 M
2020 Q2 2 3.87 k $13.0 k
2020 Q1 1 1.50 k $12.0 k
2019 Q4 2 3.87 k $13.0 k
2019 Q3 1 1.50 k $12.0 k
2019 Q2 1 1.50 k $12.0 k
2019 Q1 1 1.50 k $12.0 k